Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCQS Natural Resources Growth & Income Regulatory News (CYN)

Share Price Information for CQS Natural Resources Growth & Income (CYN)

Share Price is delayed by 15 minutes
Get Live Data
370.00    -4.00 (-1.06%)
Bid:
370.00
Ask:
377.00
Spread: 7.00 (1.892%)
Market Cap: £134.36m
CYN Live PriceLast checked at - London Stock Exchange

Intraday CQS Natural Resources Growth & Income Share Chart

Flash note from QuotedData

13 Jan 2025 11:34

RNS Number : 1058T
CQS Natural Resources Grwth&Inc PLC
13 January 2025
 

CQS Natural Resources Growth and Income - Flash note from QuotedData

13th January 2025

Protect your investment - get out and vote

On 18 December 2024, CQS Natural Resources Growth and Income (CYN) received a requisition notice from a nominee of Saba Capital Management LP (Saba) requiring it to convene a general meeting for shareholders to consider resolutions proposed by Saba to remove the existing completely-independent board of non-executive directors and replace it with two directors of Saba's choosing.

On 7 January 2025, CYN's board issued a comprehensive rebuttal of Saba's proposals when it published a circular (a formal document sent to shareholders) in relation to the requisitioned meeting - it describes Saba's proposals as "self-interested and misleading." The board's position is very clear - it is unanimous in recommending shareholders vote against Saba's resolutions.

From the outset, we have cautioned shareholders against giving full control of the trust to one dominant shareholder that would be free to act entirely in its own interests. Saba has made clear its intention to get itself appointed as manager and merge the seven targets into one large vehicle with a mandate to attack other investment companies. The FCA's (Financial Conduct Authority) Listing Rules make it clear that the board of directors of an investment company must be able to act independently of any investment manager. We are not comfortable that Saba's proposals meet this requirement.

With so much at stake, we thought we should take a deeper look at Saba's proposals and CYN's board's response to these, to see what the merits are. Our conclusion is that Saba's plans for CYN are so poor for all shareholders other than itself that its proposals deserve to be voted down comprehensively. We urge all shareholders: protect your investment and get out and vote.

Full Research:

https://quoteddata.com/research/cqs-natural-resources-growth-and-income-protect-your-investment-get-out-and-vote-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note CQS Natural Resources Growth and Income Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUOOARVAUAAAR
Date   Source Headline
12th Feb 202612:45 pmRNSNet Asset Value(s)
11th Feb 20264:22 pmRNSSale of Shares from Treasury
11th Feb 20263:13 pmRNSNet Asset Value(s)
10th Feb 20261:17 pmRNSNet Asset Value(s)
9th Feb 20262:35 pmRNSNet Asset Value(s)
6th Feb 20263:07 pmRNSNet Asset Value(s)
5th Feb 202612:32 pmRNSNet Asset Value(s)
4th Feb 202612:49 pmRNSNet Asset Value(s)
3rd Feb 20261:05 pmRNSNet Asset Value(s)
3rd Feb 20267:00 amRNSPublication of Circular and Notice of Meeting
2nd Feb 20262:37 pmRNSNet Asset Value(s)
2nd Feb 20269:24 amRNSTotal Voting Rights
30th Jan 20261:43 pmRNSNet Asset Value(s)
29th Jan 20266:07 pmRNSNet Asset Value(s)
28th Jan 202612:25 pmRNSNet Asset Value(s)
27th Jan 20264:39 pmRNSSale of Shares from Treasury
27th Jan 202612:37 pmRNSNet Asset Value(s)
26th Jan 20265:29 pmRNSSale of Shares from Treasury
26th Jan 202611:55 amRNSNet Asset Value(s)
23rd Jan 20261:21 pmRNSNet Asset Value(s)
22nd Jan 202612:13 pmRNSNet Asset Value(s)
22nd Jan 202610:51 amRNSDividend Declaration
22nd Jan 202610:44 amRNSMonthly Fact Sheet as at 31 December 2025
21st Jan 20264:58 pmRNSSale of Shares from Treasury
21st Jan 20262:06 pmRNSNet Asset Value(s)
20th Jan 20264:58 pmRNSSale of Shares from Treasury
20th Jan 202612:12 pmRNSNet Asset Value(s)
19th Jan 20261:01 pmRNSNet Asset Value(s)
16th Jan 20261:08 pmRNSNet Asset Value(s)
15th Jan 202612:54 pmRNSNet Asset Value(s)
14th Jan 202612:58 pmRNSNet Asset Value(s)
13th Jan 20265:11 pmRNSSale of Shares from Treasury
13th Jan 202612:10 pmRNSNet Asset Value(s)
12th Jan 202612:57 pmRNSNet Asset Value(s)
9th Jan 20261:52 pmRNSNet Asset Value(s)
8th Jan 202611:57 amRNSNet Asset Value(s)
7th Jan 202612:42 pmRNSNet Asset Value(s)
6th Jan 20261:06 pmRNSNet Asset Value(s)
5th Jan 20261:35 pmRNSNet Asset Value(s)
2nd Jan 20261:22 pmRNSNet Asset Value(s)
2nd Jan 202610:47 amRNSTotal Voting Rights
31st Dec 202512:30 pmRNSNet Asset Value(s)
30th Dec 20253:07 pmRNSSale of Shares from Treasury
30th Dec 20253:07 pmRNSSale of Shares from Treasury
30th Dec 202512:06 pmRNSNet Asset Value(s)
29th Dec 20252:03 pmRNSNet Asset Value(s)
24th Dec 202511:12 amRNSNet Asset Value(s)
23rd Dec 202512:45 pmRNSNet Asset Value(s)
23rd Dec 20259:18 amRNSMonthly Fact Sheet as at 30 November 2025
23rd Dec 20259:18 amRNSMonthly Fact Sheet as at 30 November 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.